MedTrace Logo

Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori

NCT02803216 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 576

Last updated 2016-09-05

No results posted yet for this study

Summary

To evaluate the efficacy and safety of Traditional Chinese Medicine (TCM) decoction and powder combined with standard triple therapy on improving eradication rate of Helicobacter Pylori (H. pylori).A multi-center randomized control clinical trial design was adopted in the trial.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

standard triple region

ten days of standard triple region (20mg omeprazole 20mg, 1.0 amoxicillin, 0.5 clarithromycin, Bid).

DRUG

2-week Xiang-sha-liu-jun decoction

2-week Xiang-sha-liu-jun decoction, bid.

DRUG

4-week Xiang-sha-liu-jun decoction

4-week Xiang-sha-liu-jun decoction, bid.

Sponsors & Collaborators

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • xudong Tang, Ph.D · XiYuan Hospital of China Academy of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-12-31
Completion
2016-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02803216 on ClinicalTrials.gov